[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
February 1979

Duration of Hepatitis B Surface Antigenemia (HBs Ag) in Hemodialysis Patients

Author Affiliations

From Newark (NJ) Beth Israel Medical Center.

Arch Intern Med. 1979;139(2):178-180. doi:10.1001/archinte.1979.03630390036015

Follow-up studies were done on 231 hemodialysis patients during a period of from one to 48 months to determine the natural history of hepatitis B surface antigenemia (HBs Ag). Of those studied, 113 (49%) exhibited HBs Ag. The probability of remaining HBs Ag positive over the mean follow-up period of 14.4 months was 62%. All of the 38 patients whose HBs Ag reverted to negative did so within ten months. Those patients whose HBs Ag reverted to negative had SGOT levels that were less frequently elevated than the patients with persistent antigenemia. Of hemodialysis patients with HBs Ag, 60% showed e antigen (HBe Ag).

(Arch Intern Med 139:178-180, 1979)